Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002313936 | SCV000739357 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-11-19 | criteria provided, single submitter | clinical testing | The c.3338C>T (p.A1113V) alteration is located in exon 21 (coding exon 21) of the NOTCH1 gene. This alteration results from a C to T substitution at nucleotide position 3338, causing the alanine (A) at amino acid position 1113 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001246312 | SCV001419656 | benign | Adams-Oliver syndrome 5 | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001246312 | SCV002553501 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269854 | SCV002553502 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505065 | SCV002816919 | uncertain significance | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-07-20 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121677 | SCV000085875 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |